Development of the CD36-Blocking Antibody PLT012 for Muscle-Invasive Bladder Cancer (MIBC)

Research unit

INNOSUISSE

Project number

133.441 IP-LS

Project title

Development of the CD36-Blocking Antibody PLT012 for Muscle-Invasive Bladder Cancer (MIBC)

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Human medicine
Abstract (English)	MIBC shows poor responses to current therapies. This project evaluates PLT012, a first-in-class anti-CD36 antibody, in advanced mouse models to overcome metabolic immune resistance. Results will guide therapeutic strategies and inform future clinical inclusion of MIBC patients.